社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Liminatus Pharma LLC(LIMN)
盘后
14.43
0.01
+0.07%
19:59 EDT
14.42
-5.89
-29.00%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
zeroxu666
·
06-05
$Liminatus Pharma LLC(LIMN)$
回顾昨日涨幅,获取的消息:Lumen Technologies (NYSE: LUMN)宣布将为JUNO跨太平洋电缆系统提供地面回程连接,该系统是连接日本和美国的最高容量跨太平洋电缆。Lumen的光纤网络将把流量从该电缆位于加州格罗弗海滩的美国登陆点传输到位于圣何塞和洛杉矶的两个主要接入点(PoP),从而助力两国的业务运营和技术进步的革新。
$Liminatus Pharma LLC(LIMN)$ 回顾昨日涨幅,获取的消息:Lumen Technologies (NYSE: LUMN)宣布将为...
回复
1
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
06-05
$Liminatus Pharma LLC(LIMN)$
回顾:重新获得纳斯达克回归
$Liminatus Pharma LLC(LIMN)$ 回顾:重新获得纳斯达克回归
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Liminatus Pharma LLC
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
- -
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Liminatus Pharma, Inc.是一家特拉华州公司,成立于2022年11月23日。Liminatus是一家临床前阶段的生物制药公司,开发新型的免疫调节癌症疗法。公司候选IBA101,是一种人源化抗CD47单抗。下一代CD47检查点抑制剂的初步适应症预计为包括非小细胞肺癌在内的晚期实体癌患者。作为一家全球领先的生物制药公司,该公司的愿景是为癌症患者开发一系列广泛的变革性疗法。
06-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-02
重要事件披露
Form 8-K/A - Current report: [Amend]
Form 8-K/A - Current report: [Amend]
06-02
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-06
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-05
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
01-28
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
01-16
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-08-10
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-08-09
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-08-07
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-07-26
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2024-06-15
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2023-11-09
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
分时
5日
日
周
月
数据加载中...
最高
18.82
今开
17.41
量比
0.33
最低
14.31
昨收
20.31
换手率
1.39%
热议股票
{"pagemeta":{"title":"Liminatus Pharma LLC(LIMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liminatus Pharma LLC(LIMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liminatus Pharma LLC,LIMN,Liminatus Pharma LLC股票,Liminatus Pharma LLC股票老虎,Liminatus Pharma LLC股票老虎国际,Liminatus Pharma LLC行情,Liminatus Pharma LLC股票行情,Liminatus Pharma LLC股价,Liminatus Pharma LLC股市,Liminatus Pharma LLC股票价格,Liminatus Pharma LLC股票交易,Liminatus Pharma LLC股票购买,Liminatus Pharma LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liminatus Pharma LLC(LIMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liminatus Pharma LLC(LIMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"LIMN","data":{"stockData":{"symbol":"LIMN","market":"US","secType":"STK","nameCN":"Liminatus Pharma LLC","latestPrice":14.42,"timestamp":1749844800000,"preClose":20.31,"halted":0,"volume":275270,"hourTrading":{"tag":"盘后","latestPrice":14.43,"preClose":14.42,"latestTime":"19:59 EDT","volume":87947,"amount":1344703.1923,"timestamp":1749859179328},"delay":0,"floatShares":19874497,"shares":26014633,"eps":-0.136308,"marketStatus":"休市中","change":-5.89,"latestTime":"06-13 16:00:00 EDT","open":17.41,"high":18.82,"low":14.31,"amount":4548133.710419999,"amplitude":0.222058,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.136308,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":20.31,"preHourTrading":{"tag":"盘前","latestPrice":17.5,"preClose":20.31,"latestTime":"09:29 EDT","volume":12256,"amount":209635.04387199998,"timestamp":1749821381562},"postHourTrading":{"tag":"盘后","latestPrice":14.43,"preClose":14.42,"latestTime":"19:59 EDT","volume":87947,"amount":1344703.1923,"timestamp":1749859179328},"volumeRatio":0.331031717780463},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.442761136889952","cardData":[{"tweetId":"442761136889952","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.07%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":40,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/LIMN\">$Liminatus Pharma LLC(LIMN)$</a> 回顾昨日涨幅,获取的消息:Lumen Technologies (NYSE: LUMN)宣布将为JUNO跨太平洋电缆系统提供地面回程连接,该系统是连接日本和美国的最高容量跨太平洋电缆。Lumen的光纤网络将把流量从该电缆位于加州格罗弗海滩的美国登陆点传输到位于圣何塞和洛杉矶的两个主要接入点(PoP),从而助力两国的业务运营和技术进步的革新。","plainDigest":"$Liminatus Pharma LLC(LIMN)$ 回顾昨日涨幅,获取的消息:Lumen Technologies (NYSE: LUMN)宣布将为JUNO跨太平洋电缆系统提供地面回程连接,该系统是连接日本和美国的最高容量跨太平洋电缆。Lumen的光纤网络将把流量从该电缆位于加州格罗弗海滩的美国登陆点传输到位于圣何塞和洛杉矶的两个主要接入点(PoP),从而助力两国的业务运营和技术进步的革新。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1749118980930,"gmtModify":1749118982203,"symbols":["LIMN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":504,"likeCount":0,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/442761136889952","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":314,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}]},{"cardType":"TWEET","cardId":"TWEET.442763986965352","cardData":[{"tweetId":"442763986965352","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.07%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":40,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/LIMN\">$Liminatus Pharma LLC(LIMN)$</a> 回顾:重新获得纳斯达克回归","plainDigest":"$Liminatus Pharma LLC(LIMN)$ 回顾:重新获得纳斯达克回归","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1749119241568,"gmtModify":1749119242727,"symbols":["LIMN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":130,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/442763986965352","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":51,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}]}],"size":2,"extra":{"requestId":"6979314f22fd4c758bfba5e26c81e5f8","feedVerCode":"2"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"19735981","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925056421-LIMN","pdf_url":"","pub_time":1749069063000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-25-056421-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.7","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925056421/tm2517129d1_ex99-7.htm","primary":true,"translateUrl":"","linkName":"tm2517129d1_ex99-7.htm","type":"EX-99.7","id":"NTFILE7PSNQSF4hbL8jB6F","market":"us","size":3898},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925056421/tm2517129d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm2517129d1_8k.htm","type":"8-K","id":"NTFILEADw855cNZ2TqsF8M","market":"us","size":30104}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-05 04:31","pubTimestamp":1749069063,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第3.01项:除牌通知或未能符合持续上市规则或标准;转让上市;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19719678","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925055078-LIMN","pdf_url":"","pub_time":1748836800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"LIMN","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/0001104659-25-055078-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/tm2516317d1_8ka.htm","primary":true,"translateUrl":"","linkName":"tm2516317d1_8ka.htm","type":"8-K/A","id":"NTFILECnaz6cDugEGrqYCk","market":"us","size":211111},{"description":"EXHIBIT 99.5","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/tm2516317d1_ex99-5.htm","primary":false,"translateUrl":"","linkName":"tm2516317d1_ex99-5.htm","type":"EX-99.5","id":"NTFILE7LNnCYeaUne2d7Lu","market":"us","size":222300},{"description":"EXHIBIT 99.6","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/tm2516317d1_ex99-6.htm","primary":false,"translateUrl":"","linkName":"tm2516317d1_ex99-6.htm","type":"EX-99.6","id":"NTFILEFwjTY2a6CdPJEvsb","market":"us","size":141071},{"description":"EXHIBIT 99.7","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/tm2516317d1_ex99-7.htm","primary":false,"translateUrl":"","linkName":"tm2516317d1_ex99-7.htm","type":"EX-99.7","id":"NTFILE9pjtDjVh1CZkTFXg","market":"us","size":352072},{"description":"EXHIBIT 99.8","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925055078/tm2516317d1_ex99-8.htm","primary":false,"translateUrl":"","linkName":"tm2516317d1_ex99-8.htm","type":"EX-99.8","id":"NTFILE2qhMS57mrkoxwqtm","market":"us","size":56732}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-02 12:00","pubTimestamp":1748836800,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19719660","market":"us","labels":[],"media":"sec.gov","original_id":"AN141057825001388-LIMN","pdf_url":"","pub_time":1748836800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"LIMN","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001388/0001410578-25-001388-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001388/limn-20250331x10q.htm","primary":true,"translateUrl":"","linkName":"limn-20250331x10q.htm","type":"10-Q","id":"NTFILEDSfjPpyvN3yStbqw","market":"us","size":324300},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001388/limn-20250331xex31d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex31d1.htm","type":"EX-31.1","id":"NTFILE5k5CGj3NDYyfuDed","market":"us","size":13137},{"description":"EX-32.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001388/limn-20250331xex32d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex32d1.htm","type":"EX-32.1","id":"NTFILEDU827dhHvxWF1MLt","market":"us","size":6828}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-06-02 12:00","pubTimestamp":1748836800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19606191","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925045127-LIMN","pdf_url":"","pub_time":1746504000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/0001104659-25-045127-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 3.03: Material Modifications to Rights of Security Holders;\nItem 4.01: Changes in Registrant's Certifying Accountant;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics;\nItem 5.06: Change in Shell Company Status;\nItem 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 2.2","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex2-2.htm","primary":true,"translateUrl":"","linkName":"tm2513673d1_ex2-2.htm","type":"EX-2.2","id":"NTFILEHzqHyUfXs29z97wr","market":"us","size":11717},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_8k.htm","type":"8-K","id":"NTFILEBgQ5RdHktrQ9YgmP","market":"us","size":243958},{"description":"EXHIBIT 2.3","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex2-3.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex2-3.htm","type":"EX-2.3","id":"NTFILEBGbLFPBw6QuPAtHW","market":"us","size":23582},{"description":"EXHIBIT 3.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex3-1.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex3-1.htm","type":"EX-3.1","id":"NTFILEAvGoQYU2BvR4wBsM","market":"us","size":49947},{"description":"EXHIBIT 4.4","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex4-4.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex4-4.htm","type":"EX-4.4","id":"NTFILE4EfDp9NJkJ35jVoK","market":"us","size":15087},{"description":"EXHIBIT 10.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex10-1.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex10-1.htm","type":"EX-10.1","id":"NTFILEB96y8dQ1s8v8CQCh","market":"us","size":128657},{"description":"EXHIBIT 14.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex14-1.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex14-1.htm","type":"EX-14.1","id":"NTFILEBoF5AEmyd1oEiTrc","market":"us","size":39967},{"description":"EXHIBIT 16.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex16-1.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex16-1.htm","type":"EX-16.1","id":"NTFILEGz7iAwCb1c6uZFmX","market":"us","size":2938},{"description":"EXHIBIT 21.1","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex21-1.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex21-1.htm","type":"EX-21.1","id":"NTFILEEEBs5foSZqJWcrj4","market":"us","size":1952},{"description":"EXHIBIT 99.1","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex99-1.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex99-1.htm","type":"EX-99.1","id":"NTFILEFpE7j1ftow9N3RQb","market":"us","size":90109},{"description":"EXHIBIT 99.2","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex99-2.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex99-2.htm","type":"EX-99.2","id":"NTFILEFmMhSR8oqttYUSYc","market":"us","size":231800},{"description":"EXHIBIT 99.3","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925045127/tm2513673d1_ex99-3.htm","primary":false,"translateUrl":"","linkName":"tm2513673d1_ex99-3.htm","type":"EX-99.3","id":"NTFILEGZPf7bmNpdEnC5MH","market":"us","size":323824}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-06 12:00","pubTimestamp":1746504000,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19218334","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925009006-LIMN","pdf_url":"","pub_time":1738691843000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-25-009006-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925009006/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEuHPFiVPfF6XXZH45","market":"us","size":6620}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-02-05 01:57","pubTimestamp":1738691843,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19218332","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925006324-LIMN","pdf_url":"","pub_time":1738012200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-25-006324-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925006324/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE2XezQFN1wNUnHikF","market":"us","size":11133}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-01-28 05:10","pubTimestamp":1738012200,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19218339","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925003831-LIMN","pdf_url":"","pub_time":1736980513000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-25-003831-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925003831/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEHXQbSyUAG1esA7DA","market":"us","size":28464}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-01-16 06:35","pubTimestamp":1736980513,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18605259","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924087852-LIMN","pdf_url":"","pub_time":1723236990000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-24-087852-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465924087852/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILECM9pZKQaGGQxVUza","market":"us","size":6840}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-08-10 04:56","pubTimestamp":1723236990,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18605244","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924087438-LIMN","pdf_url":"","pub_time":1723164433000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-24-087438-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465924087438/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE9CjLLMttTbsJBiJc","market":"us","size":11837}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-08-09 08:47","pubTimestamp":1723164433,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18605253","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924086584-LIMN","pdf_url":"","pub_time":1723036121000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-24-086584-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465924086584/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEE6RgrwTeuxjmJoxz","market":"us","size":11444}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-08-07 21:08","pubTimestamp":1723036121,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18605240","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924082707-LIMN","pdf_url":"","pub_time":1721942791000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-24-082707-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465924082707/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEH4cWAnAeUoUduYqe","market":"us","size":21887}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-07-26 05:26","pubTimestamp":1721942791,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18605242","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465924071651-LIMN","pdf_url":"","pub_time":1718386698000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-24-071651-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465924071651/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEBiMMxAXYSBVANDfK","market":"us","size":33970}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2024-06-15 01:38","pubTimestamp":1718386698,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18605245","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465923115802-LIMN","pdf_url":"","pub_time":1699481112000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-23-115802-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465923115802/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEFHByrkKeVLLS5381","market":"us","size":105013}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2023-11-09 06:05","pubTimestamp":1699481112,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"stockEarnings":[{"period":"1week","weight":-0.4046},{"period":"1month","weight":1.2185},{"period":"3month","weight":-0.0387},{"period":"6month","weight":0.2772},{"period":"1year","weight":0.2956},{"period":"ytd","weight":0.2852}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":0.016},{"period":"3month","weight":0.0607},{"period":"6month","weight":-0.0119},{"period":"1year","weight":0.1006},{"period":"ytd","weight":0.0186}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liminatus Pharma, Inc.是一家特拉华州公司,成立于2022年11月23日。Liminatus是一家临床前阶段的生物制药公司,开发新型的免疫调节癌症疗法。公司候选IBA101,是一种人源化抗CD47单抗。下一代CD47检查点抑制剂的初步适应症预计为包括非小细胞肺癌在内的晚期实体癌患者。作为一家全球领先的生物制药公司,该公司的愿景是为癌症患者开发一系列广泛的变革性疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009402},{"month":2,"riseRate":1,"avgChangeRate":0.015297},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065679},{"month":4,"riseRate":0.5,"avgChangeRate":-0.073295},{"month":5,"riseRate":0.25,"avgChangeRate":-0.001827},{"month":6,"riseRate":0.6,"avgChangeRate":0.325282},{"month":7,"riseRate":0.5,"avgChangeRate":-0.009101},{"month":8,"riseRate":0.25,"avgChangeRate":-0.003864},{"month":9,"riseRate":0.5,"avgChangeRate":0.000157},{"month":10,"riseRate":0.75,"avgChangeRate":0.008479},{"month":11,"riseRate":0.5,"avgChangeRate":-0.003101},{"month":12,"riseRate":0.75,"avgChangeRate":0.009144}],"exchange":"NASDAQ","name":"Liminatus Pharma LLC","nameEN":"Liminatus Pharma LLC"},"aProfile":null}}}